Clinical Trials Directory

Trials / Completed

CompletedNCT01781169

Vitamin D Supplementation to Obese Chinese Males

Health Effect of Oral Vitamin D Supplementation on Obese Chinese Males

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Shenzhen Center for Chronic Disease Control · Academic / Other
Sex
Male
Age
23 Years – 66 Years
Healthy volunteers
Accepted

Summary

Hypothesis: Oral Supplementation of Vitamin D can Reduce Hypersecretion of Parathyroid Hormone and Insulin Resistance in Obese Chinese Males. Protocol: Weekly oral supplementation of 50,000 IU vitamin D (cholecalciferol) or eight weeks to the obese males compared with the normal-weight males. Index measures were conducted at baseline and endpoint.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOral supplementation of vitamin DWeekly oral supplementation of 50,000 IU vitamin D (cholecalciferol) for eight weeks to the obese males compared with the normal-weight males. The chemical form of vitamin D is cholecalciferol capsuled as fine powder.

Timeline

Start date
2011-04-01
Primary completion
2011-12-01
Completion
2012-12-01
First posted
2013-01-31
Last updated
2013-10-30
Results posted
2013-09-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01781169. Inclusion in this directory is not an endorsement.